Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Ewing's sarcoma and related subtypes of primitive neuroectodermal tumours share a recurrent and specific t(11;22) (q24;q12) chromosome translocation, the breakpoints of which have recently been cloned. Phylogenetically conserved restriction fragments in the vicinity of EWSR1 and EWSR2, the genomic regions where the breakpoints of chromosome 22 and chromosome 11 are, respectively, have allowed identification of transcribed sequences from these regions and has indicated that a hybrid transcript might be generated by the translocation. Here we use these fragments to screen human complementary DNA libraries to show that the translocation alters the open reading frame of an expressed gene on chromosome 22 gene by substituting a sequence encoding a putative RNA-binding domain for that of the DNA-binding domain of the human homologue of murine Fli-1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ewing’s sarcoma, a common pediatric cancer, is invariably associated with ETS gene translocations (182) that result in a fusion oncogene consisting of the 5′ end of EWS and the 3′ end of FLI1, or less frequently ERG, ETV1, ETV4, or FEV (Figure 1a) (183, 184).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [183]
Citations
Cites
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
Transcriptional Regulation in Mammalian Cells by Sequence-Specific DNA Binding Proteins
Mitchell, P. J., & Tjian, R. (1989) · Science · doi:10.1126/science.2667136 · Cited by 3,114
RNA recognition: towards identifying determinants of specificity
Kenan, D. J., Query, C. C., & Keene, J. D. (1991) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(91)90088-d · Cited by 730
RNA-binding proteins as developmental regulators.
Bandziulis, R. J., Swanson, M. S., & Dreyfuss, G. (1989) · Genes & Development · doi:10.1101/gad.3.4.431 · Cited by 644
Turc-Carel, C., Aurias, A., Mugneret, F., Lizard, S., Sidaner, I., Volk, C., Thiery, J. P., Olschwang, S., Philip, I., Berger, M. P., et al. (1988) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(88)90285-3 · Cited by 466
Self-citationBen-David, Y., Giddens, E. B., Letwin, K., & Bernstein, A. (1991) · Genes & Development · doi:10.1101/gad.5.6.908 · Cited by 403
Chromosome Translocation in Peripheral Neuroepithelioma
Whang-Peng, J., Triche, T. J., Knutsen, T., Miser, J., Douglass, E. C., & Israel, M. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408303110907 · Cited by 399
Chromosomal Translocations in Ewing's Sarcoma
(1983) · New England Journal of Medicine · doi:10.1056/nejm198308253090817 · Cited by 330
Corden, J. L. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90236-5 · Cited by 327
Turc-Carel, C., Philip, I., Berger, M.-P., Philip, T., & Lenoir, G. M. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90002-5 · Cited by 291
Research works printed but not linked: 8
- Aurias, A., Rimbaut, C., Buffe, C., Dubousset, J. & Mazabraud, A. N. Engl. J. Med. 309, 496–497 (1983).
- Turc-Carel, C., Philip, I., Berge, R. M. P., Philip, T. & Lenoir, G. M. N. Engl. J. Med. 309, 497–498 (1983).
- De Chadarevian, J. P., Vekemans, M. & Seemayer, T. A. N. Engl. J. Med. 311, 1702–1703 (1984).
- Cavazzana, A. O. et al. Adv. Neuroblastoma Res. 2, 463–473 (1988).
- Zucman, J. et al. Genes Chrom. Cancer (in the press).
- Douglass, E. C., Valentine, M., Green, A. A., Hayes, F. A. & Thompson, E. I. J. natn. Cancer Inst. 77, 1211–1213 (1986).
- Watson, D. K., Ascione, R. & Papas, T. S. Crit. Rev. Oncogenesis 1, 409–436 (1990).
- Rouleau, G. A. et al. Am. J. hum. Genet. 46, 323–328 (1990).
Cited by
Items 301–400 of 1,002
Ng, K. P., Potikyan, G., Savene, R. O. V., Denny, C. T., Uversky, V. N., & Lee, K. A. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607007104 · Cited by 104
Im, Y. H., Kim, H. T., Lee, C., Poulin, D., Welford, S. M., Sorensen, P. H., Denny, C. T., & Kim, S. (2000) · PubMed · Cited by 104
Epidemiology of bone tumours in children and young adults
Eyre, R., Feltbower, R. G., Mubwandarikwa, E., Eden, T. O. B., & McNally, R. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22194 · Cited by 116
Understanding the Role of ETS-Mediated Gene Regulation in Complex Biological Processes
Findlay, V. J., LaRue, A. C., Turner, D. P., Watson, P. M., & Watson, D. K. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00001-0 · Cited by 125
Zoubek, A., Pfleiderer, C., Salzer-Kuntschik, M., Amann, G., Windhager, R. H., Fink, F. M., Kościelniak, E., Delattre, O., Strehl, S., Ambros, P. F., et al. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.419 · Cited by 103
Self-citationFusion genes in solid tumors: an emerging target for cancer diagnosis and treatment
Parker, B. C., & Zhang, W. (2013) · Chinese Journal of Cancer · doi:10.5732/cjc.013.10178 · Cited by 94
A Short History of Chromosome Rearrangements and Gene Fusions in Cancer
Mitelman, F. (2015) · Springer eBooks · doi:10.1007/978-3-319-19983-2_1 · Cited by 103
Choi, E.-Y. K., Gardner, J. M., Lucas, D. R., McHugh, J. B., & Patel, R. M. (2014) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2014.01.002 · Cited by 105
Vassal, G., Terrier-Lacombe, M.-J., Bissery, M.-C., Vénuat, A. M., Gyergyay, F., Bénard, J., Morizet, J., Boland, I., Ardouin, P., Paillerets, B. B., et al. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.398 · Cited by 102
“The presence of the EWS -FLI fusion transcript in the SK- N-MC xenograft was detected by reverse transcriptasepolymerase chain reaction (RT-PCR) analysis of total RNA, as described previously (Delattre et al., 1992).”
MethodVisceral primitive peripheral neuroectodermal tumors: A clinicopathologic and molecular study
O’Sullivan, M. J., Perlman, E. J., Furman, J., Humphrey, P. A., Dehner, L. P., & Pfeifer, J. D. (2001) · Human Pathology · doi:10.1053/hupa.2001.28247 · Cited by 102
Aberrant phase separation and cancer
Taniue, K., & Akimitsu, N. (2021) · FEBS Journal · doi:10.1111/febs.15765 · Cited by 106
Single Enantiomer of YK-4-279 Demonstrates Specificity in Targeting the Oncogene EWS-FLI1
Barber-Rotenberg, J. S., Selvanathan, S. P., Kong, Y., Erkizan, H. V., Snyder, T. M., Hong, S. P., Kobs, C. L., South, N. L., Summer, S., Monroe, P. J., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.454 · Cited by 103
“We tested cells containing all three major variant translocation types of Ewing’s sarcoma and this difference cannot be attributed to the specific translocation [3].”
BackgroundAraya, N., Hirota, K., Shimamoto, Y., Miyagishi, M., Yoshida, E., Ishida, J., Kaneko, S., Kaneko, M., Nakajima, T., & Fukamizu, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210234200 · Cited by 101
Oettgen, P., Kas, K., Dube, A., Gu, X., Grall, F., Thamrongsak, U., Akbarali, Y., Finger, E., Boltax, J., Endress, G., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29439 · Cited by 100
Karnieli, E., Werner, H., Rauscher, F. J., Benjamin, L. E., & LeRoith, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19304 · Cited by 116
Downing, J. R., Khandekar, A. K., Shurtleff, S. A., Head, D. R., Parham, D. M., Webber, B. L., Pappo, A. S., Hulshof, M., Conn, W. P., & Shapiro, D. N. (1995) · PubMed · Cited by 104
Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma
Krumbholz, M., Hellberg, J., Steif, B., Bäuerle, T., Gillmann, C., Fritscher, T., Agaimy, A., Frey, B., Juengert, J., Wardelmann, E., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-3028 · Cited by 96
Scotlandi, K., Serra, M., Manara, M. C., Benini, S., Sarti, M., Maurici, D., Lollini, P., Picci, P., Bertoni, F., & Baldini, N. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90115-x · Cited by 100
Zhu, H., Uusküla-Reimand, L., Isaev, K., Wadi, L., Alizada, A., Shuai, S., Huang, V., Aduluso-Nwaobasi, D., Paczkowska, M., Abd-Rabbo, D., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2019.12.027 · Cited by 101
Ulaner, G. A., Hoffman, A. R., Otero, J. E., Huang, H., Zhao, Z., Mazumdar, M., Gorlick, R. G., Meyers, P. A., Healey, J. H., & Ladanyi, M. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20074 · Cited by 115
“Ewing’s sarcomas consistently contain specific translocations that result in the fusion of the EWSR1 gene, at 22q12, and a gene of the ETS family of transcription factors (Delattre et al., 1992; Zucman et al., 1993).”
BackgroundKawauchi, S., Fukuda, T., Miyamoto, S., Yoshioka, J.-I., Shirahama, S., Saito, T., & Tsukamoto, N. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199811000-00013 · Cited by 99
Chansky, H. A., Barahmand-Pour, F., Mei, Q., Kahn‐Farooqi, W., Zielinska‐Kwiatkowska, A., Blackburn, M. L., Chansky, K., Conrad, E. U., Bruckner, J. D., Greenlee, T. K., et al. (2004) · Journal of Orthopaedic Research® · doi:10.1016/j.orthres.2003.12.008 · Cited by 108
“008 EWS with the DNA-binding domain of the ETS family transcription factor FLI-1 [8].”
BackgroundHoos, A., Hepp, H. H., Kaul, S., Ahlert, T., Bastert, G., & Wallwiener, D. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980220)79:1<8::aid-ijc2>3.0.co;2-5 · Cited by 72
Self-citationOlfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma.
Sorensen, P. H., Wu, J., Berean, K. W., Lim, J. F., Donn, W., Frierson, H. F., Reynolds, C. P., López-Terrada, D., & Triche, T. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1038 · Cited by 101
Rorie, C. J., Thomas, V. D., Chen, P., Pierce, H., O’Bryan, J. P., & Weissman, B. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3274 · Cited by 98
Lin, P. P., Pandey, M. K., Jin, F., Xiong, S., Deavers, M., Parant, J. M., & Lozano, G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0573 · Cited by 95
“The chimeric gene EWS-FLI1 is associated with Ewing’s sarcoma (1).”
BackgroundSozzi, G., Bongarzone, I., Miozzo, M. R., Borrello, M. G., Butti, M. G., Porta, G. D., Pierotti, M. A., & Pilotti, S. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870090404 · Cited by 98
“underlying lineage-specific tumorigenesis (Aman et al., 1992; Delattre et al., 1992; Barr et al., 1993).”
Inhibition of EWS-FLI-1 fusion protein with antisense oligodeoxynucleotides
Toretsky, J. A., Connell, Y., Neckers, L., & BHAT, N. K. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005716926800 · Cited by 107
“Ewing’s family of tumors (EFT) have been shown to contain a t(11;22)(q24;q12) reciprocal translocation which generates a chimeric fusion protein containing the amino-terminal portion of the Ewing’s sarcoma gene (EWS) and carboxyl-terminus of FLI-1 protein [10].”
BackgroundMDM2 and CDK4 gene amplification in Ewing's sarcoma
Ladanyi, M., Lewis, R., Jhanwar, S. C., Gerald, W., Huvos, A. G., & Healey, J. H. (1995) · The Journal of Pathology · doi:10.1002/path.1711750209 · Cited by 98
Labelle, Y., Bussières, J., Courjal, F., & Goldring, M. B. (1999) · Oncogene · doi:10.1038/sj.onc.1202675 · Cited by 105
“It was originally discovered as being fused to the transcription factor FLI-1 by the t(11;22) chromosomal translocation found in the Ewing's sarcoma family of tumors (Delattre et al., 1992).”
BackgroundSynovial Sarcoma: From Genetics to Genetic-based Animal Modeling
Haldar, M., Randall, R. L., & Capecchi, M. R. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0340-2 · Cited by 95
“motifs, one SH3-binding motif, and a C-terminal QPGY domain rich in glutamine, proline, glycine, and tyrosine that is similar to the transcriptional activation region within the EWS/FUS/TLS family of proteins [ 17 , 79].”
BackgroundFLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells
Athanasiou, M., Mavrothalassitis, G., Sun-Hoffman, L., & Blair, D. (2000) · Leukemia · doi:10.1038/sj.leu.2401689 · Cited by 111
Dohjima, T., Lee, N. S., Li, H., Ohno, T., & Rossi, J. J. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00101-1 · Cited by 103
Calcium-induced phosphorylation of ETS1 inhibits its specific DNA binding activity.
Rabault, B., & Ghysdael, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46906-2 · Cited by 94
A chromatin structure‐based model accurately predicts DNA replication timing in human cells
Gindin, Y., Valenzuela, M. S., Aladjem, M. I., Meltzer, P. S., & Bilke, S. (2014) · Molecular Systems Biology · doi:10.1002/msb.134859 · Cited by 94
“Recurrent chromosomal fusions are found in many cancers (Rowley, 1973; Delattre et al, 1992; Tomlins et al, 2005).”
BackgroundContext matters: The hen or egg problem in Ewing's sarcoma
Kovar, H. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.01.004 · Cited by 108
Self-citationLuo, W., Gangwal, K., Sankar, S., Boucher, K. M., Thomas, D., & Lessnick, S. L. (2009) · Oncogene · doi:10.1038/onc.2009.262 · Cited by 93
“Keywords: Ewing’s sarcoma; EWS/FLI; GSTM4; transformation Most cases of Ewing’s sarcoma harbor recurrent chromosomal translocations, the most common of which encodes the EWS/FLI fusion oncoprotein (Delattre et al., 1992).”
BackgroundInfluentialHarlow, M. L., Maloney, N., Roland, J. T., Navarro, M. J. G., Easton, M. K., Kitchen-Goosen, S. M., Boguslawski, E. A., Madaj, Z., Johnson, B. K., Bowman, M. J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0568 · Cited by 93
“INTRODUCTION Ewing sarcoma is a bone and soft-tissue sarcoma that depends on the continued activity of the EWS-FLI1 transcription factor, which is formed by the t(11;22)(q24;q12) chromosomal translocation (1,2).”
MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor
Franzetti, G.-A., Laud-Duval, K., Bellanger, D., Stern, M., Sastre‐Garau, X., & Delattre, O. (2012) · Oncogene · doi:10.1038/onc.2012.403 · Cited by 101
Self-citationPRMT1 mediated methylation of TAF15 is required for its positive gene regulatory function
Jobert, L., Argentini, M., & Tora, L. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.12.008 · Cited by 101
Lončarević, I., Roitzheim, B., Ritterbach, J., Viehmann, S. F., Borkhardt, A., Lampert, F. H., & Harbott, J. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199903)24:3<238::aid-gcc9>3.3.co;2-d · Cited by 61
Prognostic profiling of the immune cell microenvironment in Ewing´s Sarcoma Family of Tumors
Stahl, D. J., Gentles, A. J., Thiele, R., & Gütgemann, I. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1674113 · Cited by 109
“the EWS-FLI1 t(11;22)(q24;q12) (85%) with type 1 (exon 7 of EWS to exon 6 of FLI1) and type 2 (exon 7 of EWS to exon 5 of FLI1).(1) In another 10-15% of cases, alternative transloca-”
BackgroundBiegel, J. A., Conard, K. A., & Brooks, J. J. S. (1993) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870070210 · Cited by 92
Ewing Sarcoma Protein: A Key Player in Human Cancer
Paronetto, M. P. (2013) · International Journal of Cell Biology · doi:10.1155/2013/642853 · Cited by 91
“Hindawi Publishing Corporation International Journal of Cell Biology Volume 2013, Article ID 642853, 12 pages http://dx.doi.org/10.1155/2013/642853 Review Article Ewing Sarcoma Protein: A Key Player in Human Cancer Maria Paola Paronetto1,2 1 Department of Health Sciences, University of Rome “Foro Italico”, 00135 Rome,…”
InfluentialTransforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity
Jaishankar, S., Zhang, J., Roussel, M. F., & Baker, S. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202940 · Cited by 102
“This genetic alteration generates a novel inframe fusion gene between sequences encoding the Nterminus of the RNA binding protein EWS, and the Cterminus of FLI-1, a member of the ETS family of transcription factors (Delattre et al., 1992).”
BackgroundDetection of tumour cells in peripheral blood and bone marrow from ewing tumour patients by rt‐pcr
Pfleiderer, C., Zoubek, A., Gruber, B., Kronberger, M., Ambros, P. F., Lion, T., Fink, F., Gadner, H., & Kovar, H. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640211 · Cited by 90
Self-citationStructure–Function Relationships of the PEA3 Group of Ets-Related Transcription Factors
de Launoit, Y., Baert, J.-L., Chotteau, A., Monte, D., Defossez, P.-A., Coutte, L., Pelczar, H., & Leenders, F. (1997) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1997.2605 · Cited by 90
Orth, M. F., Surdez, D., Faehling, T., Ehlers, A. C., Marchetto, A., Grossetête, S., Volckmann, R., Zwijnenburg, D. A., Gerke, J. S., Zaïdi, S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111761 · Cited by 92
Self-citationZhu, L., McManus, M. M., & Hughes, D. P. M. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00230 · Cited by 98
“This disease is most often characterized by a chromosomal translocation between chromosome 11 and 22, generating the EWS-FLI1 fusion gene (5).”
BackgroundChandhanayingyong, C., Kim, Y., Staples, J. R., Hahn, C., & Lee, F. Y. (2012) · Sarcoma · doi:10.1155/2012/404810 · Cited by 97
Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor
Soldatenkov, V. A., Albor, A., Patel, B. K. R., Dreszer, R., Dritschilo, A., & Notario, V. (1999) · Oncogene · doi:10.1038/sj.onc.1202778 · Cited by 90
“Second, the oncogenic conversion of Fli-1, Erg and other Ets related genes via gene fusion has been reported in EWS cells (Delattre et al., 1992; May et al., 1993; Sorensen et al., 1994; Jeon et al., 1995; Peter et al., 1997).”
BackgroundMethodInfluentialDistinct genomic aberrations associated with ERG rearranged prostate cancer
Demichelis, F., Setlur, S. R., Beroukhim, R., Perner, S., Korbel, J. O., LaFargue, C. J., Pflueger, D., Pina, C., Hofer, M. D., Sboner, A., et al. (2009) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20647 · Cited by 91
“In the case of EWS rearrangements in leukemia, the genomic breakpoints have been determined to be tightly clustered for the EWS locus (<8 Kb region), whereas the breakpoints of its partner FLI1, occurs over a larger 35 Kb region in Ewing’s family tumors (Delattre et al., 1992).”
BackgroundMolecular Diagnosis in Ewing Family Tumors
Gamberi, G., Cocchi, S., Benini, S., Magagnoli, G., Morandi, L., Kreshak, J., Gambarotti, M., Picci, P., Zanella, L., & Alberghini, M. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2011.01.004 · Cited by 89
Tomlinson, G. E., Douglass, E. C., Pollock, B. H., Finegold, M. J., & Schneider, N. R. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20227 · Cited by 89
“This observation underscores the hypothesis that a specific disruption in 1q12–21 may be a critical factor in tumorigenesis rather than the formation of a specific chimeric gene product, as observed in other tumor types with specific recurring translocations (Delattre et al., 1992; Knezevich et al., 1998).”
BackgroundDong, Y., Perriman, R., Igel, H., Howe, K. J., Neville, M. C., & Ares, M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.5000 · Cited by 98
“Those containing acidic substitutions at the normally aromatic position 3 of RNP-1 include EWS (Ewing’s sarcoma [27]), FUS/TLS (25) (also known as hnRNP P2 [20]), and hTAFII68 (14).”
BackgroundKobayashi, H., Montgomery, K., Bohlander, S. K., Adra, C., Lim, B., Kucherlapati, R. S., Donis-Keller, H., Holt, M., Beau, M. M. L., & Rowley, J. (1994) · Blood · doi:10.1182/blood.v84.10.3473.3473 · Cited by 98
Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward?
Lawlor, E. R., & Sorensen, P. H. B. (2015) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2015013553 · Cited by 105
Danieau, G., Morice, S., Rédiní, F., Verrecchia, F., & Royer, B. B.-L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153751 · Cited by 93
“In contrast to osteosarcoma, Ewing sarcoma is characterized by a chromosomal translocation between the EWSR1 and FLI1 genes in 90% of cases, or by the fusion of EWSR1 with other transcription factors of the E26 Transformation-Specific (ETS) gene family in 10% of cases [6–8].”
Role of immunotherapy in Ewing sarcoma
Morales, E., Olson, M., Cardenas, F. I., Dahiya, S., Luetkens, T., & Atanackovic, D. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000653 · Cited by 98
Al-Halabi, K., Stichel, D., Sievers, P., Peterziel, H., Sommerkamp, A. C., Sturm, D., Wittmann, A., Sill, M., Jäger, N., Beck, P., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02354-8 · Cited by 92
The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties
Bertolotti, A., Bell, B., & Tora, L. (1999) · Oncogene · doi:10.1038/sj.onc.1203207 · Cited by 93
“By alignment of TAFII68 and EWS proteins and their genomic sequences (data not shown), we found that the ®rst 159 amino acids of TAFII68 correspond to the domain of EWS present in the type II EWS-FLI-1 fusion proteins (Delattre et al., 1992).”
BackgroundEwing’s sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors
Tanaka, M., Yamazaki, Y., Kanno, Y., Igarashi, K., Aisaki, K., Kanno, J., & Nakamura, T. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72399 · Cited by 97
“The EWS and the transcription factor ETS ( EWS-ETS ) fusion is now considered a genetic hallmark of human Ewing’s sarcoma (5–7).”
Genetic imbalances revealed by comparative genomic hybridization in Ewing tumors
Ozaki, T., Paulussen, M., Poremba, C., Brinkschmidt, C., Rerin, J., Ahrens, S., Hoffmann, C., Hillmann, A., Wai, D., Schaefer, K., et al. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1178 · Cited by 89
“Molecular genetic analysis has demonstrated a fusion of the EWS gene and genes encoding a member of the ETS family of transcription factors (Delattre et al., 1992).”
BackgroundCholecystokinin Down-Regulation by RNA Interference Impairs Ewing Tumor Growth
Carrillo, J., García-Aragoncillo, E., Azorín, D., Agrá, N., Sastre, A., González‐Mediero, I., García‐Miguel, P., Pestaña, Á., Gallego, S., Segura, D., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1762 · Cited by 94
Sato, Y., Nabeta, Y., Tsukahara, T., Hirohashi, Y., Syunsui, R., Maeda, A., Sahara, H., Ikeda, H., Torigoe, T., Ichimiya, S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1611 · Cited by 86
“Recently, chimeric fusion genes resulting from tumor-specific chromosomal translocations have been identified in several types of soft tissue sarcomas, including SYT-SSX in synovial sarcoma (3–5), EWSFli1 in Ewing’s sarcoma (6), and TLS-CHOP in myxoid/round cell liposarcoma (7, 8).”
BackgroundBertrand, P., Akhmedov, A. T., Delacôte, F., Dürrbach, A., & López, B. S. (1999) · Oncogene · doi:10.1038/sj.onc.1203048 · Cited by 99
“In sarcomas or leukemias, chromosomal translocation of TLS or EWS with speci®c partners creates fusion oncoproteins (Delattre et al., 1992; Crozat et al., 1993; Rabbitts et al., 1993; Ichikawa et al., 1994).”
BackgroundTranscription factors, translocations, and leukemia
Nichols, J., & Nimer, S. (1992) · Blood · doi:10.1182/blood.v80.12.2953.2953 · Cited by 87
EWS/ETS fusions activate telomerase in Ewing's tumors.
Takahashi, A., Higashino, F., Aoyagi, M., Yoshida, K., Itoh, M., Kyo, S., Ohno, T., Taira, T., Ariga, H., Nakajima, K., et al. (2003) · PubMed · Cited by 102
Lawlor, E. R., Scheel, C., Irving, J. A., & Sorensen, P. H. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205053 · Cited by 100
“…by the presence of a novel fusion gene resulting from chromosomal translocation between the EWS locus on chromosome 22q23 and various members of the ETS gene family, usually either the FLI1 gene on chromosome 11q22 or the ERG gene on chromosome 21q22 (Delattre et al., 1992; Sorensen et al., 1994).”
BackgroundAthanasiou, M., Clausen, P. A., Mavrothalassitis, G. J., Zhang, X. K., Watson, D. K., & Blair, D. G. (1996) · PubMed · Cited by 102
Characterization of NERF, a Novel Transcription Factor Related to the Ets Factor ELF-1
Oettgen, P., Akbarali, Y., Boltax, J., Best, J., Kunsch, C., & Libermann, T. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.5091 · Cited by 85
“Ewing’s sarcoma is characterized by translocations involving either erg, fli-1, or ETV-1, three closely related ets factors, and the EWS gene (17, 37, 97), whereas in a subset of AML erg is translocated to the FUS gene (66).”
BackgroundTargeting chromatin complexes in fusion protein-driven malignancies
Brien, G. L., Stegmaier, K., & Armstrong, S. A. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0132-x · Cited by 86
Hill, D. A., O’Sullivan, M. J., Zhu, X., Vollmer, R. T., Humphrey, P. A., Dehner, L. P., & Pfeifer, J. D. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200208000-00001 · Cited by 84
Johnson, K. M., Mahler, N., Saund, R. S., Theisen, E. R., Taslim, C., Callender, N. W., Crow, J. C., Miller, K. R., & Lessnick, S. L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701872114 · Cited by 90
“E sarcoma is an aggressive bone malignancy of children, adolescents, and young adults (1).”
BackgroundPanagopoulos, I., Mencinger, M., Dietrich, C. U., Bjerkehagen, B., Sæter, G., Mertens, F., Mandahl, N., & Heim, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203155 · Cited by 83
“…by means of a t(11;22)(q24;q12) or one of four variant translocations, t(21;22)(q22;q12), t(7;22) (p22;q12), t(17;22)(q12;q12) and t(2;22)(q33;q12) (Delattre et al., 1992; Zucman et al., 1993b; Sorensen et al., 1994; Jeon et al., 1995; Kaneko et al., 1996; Urano et al., 1996; Peter et al., 1997).”
BackgroundHisaoka, M., Tsuji, S., Morimitsu, Y., Hashimoto, H., Shimajiri, S., Komiya, S., & Ushijima, M. (1998) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199804000-00006 · Cited by 83
Tarkkanen, M., Kiuru‐Kuhlefelt, S., BLOMQVIST, C. P., Armengol, G., Böhling, T., Ekfors, T., Virolainen, M. J., Lindholm, P., Monge, O. R., Picci, P., et al. (1999) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00031-x · Cited by 87
“In two recent studies, fusion type I [9] was associated with a better prognosis [15, 16].”
BackgroundDhordain, P., Dewitte, F., Desbiens, X., Stéhelin, D., & Duterque‐Coquillaud, M. (1995) · Mechanisms of Development · doi:10.1016/0925-4773(94)00322-e · Cited by 91
Molecular Analysis of Ewing's Sarcoma: Another Fusion Gene, EWS‐E1AF, Available for Diagnosis
Urano, F., Umezawa, A., Yabe, H., Hong, W., Yoshida, K., Fujinaga, K., & Hata, J. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb03274.x · Cited by 93
Lorin, S., Borges, A., Ribeiro Dos Santos, L., Souquère, S., Pierron, G., Ryan, K. M., Codogno, P., & Djavaheri-Mergny, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1270 · Cited by 82
Characterization of the ets oncogene family member, fli-1.
Klemsz, M. J., Maki, R. A., Papayannopoulou, T., Moore, J., & Hromas, R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53385-8 · Cited by 84
Biegel, J. A., Nycum, L. M., Valentine, V. A., Barr, F. G., & Shapiro, D. N. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870120305 · Cited by 82
The PEA3 Group of ETS-related Transcription Factors
de Launoit, Y., Chotteau‐Lelièvre, A., Beaudoin, C., Coutte, L., Netzer, S., Brenner, C., Huvent, I., & Baert, J. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46832-8_13 · Cited by 82
Ferreira, B. I., Alonso, J., Carrillo, J., Acquadro, F., Largo, C., Suela, J., Teixeira, M. R., Cerveira, N., Molares-Vila, A., Goméz-López, G., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210845 · Cited by 81
“The t(11;22) translocation leads to the fusion of the EWS gene on 22q12 with the FLI1 gene on 11q24, resulting in the formation and expression of the chimaeric transcript EWS-FLI1 (Delattre et al., 1992) that is thought to contribute to the pathogenesis of this tumour by modulating the expression of target genes.”
BackgroundEwing Sarcoma/Peripheral Primitive Neuroectodermal Tumor and Related Tumors
Tsokos, M., Alaggio, R., Dehner, L. P., & Dickman, P. S. (2012) · Pediatric and Developmental Pathology · doi:10.2350/11-08-1078-pb.1 · Cited by 88
“The 2 most frequently observed in-frame fusions are the type 1 between EWS exon 7 and FLI1 exon 6 and the type 2 between EWS exon 7 and FLI1 exon 5 [123], which occur in approximately 60% and 25% of the cases, respectively [127].”
BackgroundAgelopoulos, K., Richter, G. H. S., Schmidt, E., Dirksen, U., von Heyking, K., Moser, B., Klein, H.-U., Kontny, U., Dugas, M., Poos, K., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2744 · Cited by 79
“as a consequence of the t(11;22)(q24;q12) translocation (8–11).”
BackgroundEWSR1 fusion proteins mediate PAX7 expression in Ewing sarcoma
Charville, G. W., Wang, W., Ingram, D. R., Roy, A., Thomas, D. G., Patel, R. M., Hornick, J. L., van de Rijn, M., & Lazar, A. J. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.49 · Cited by 81
Grohar, P. J., Glod, J. W., Peer, C. J., Sissung, T. M., Arnaldez, F. I., Long, L., Figg, W. D., Whitcomb, P. O., Helman, L. J., & Widemann, B. C. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3382-x · Cited by 81
“1 3 factor is generated by a t(11;22)(q24;q12) chromosomal translocation [5].”
BackgroundExpression of two ATP-gated ion channels, P2X5 and P2X6, in developing chick skeletal muscle
Meyer, M. P., Gr�schel-Stewart, U., Robson, T., & Burnstock, G. (1999) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199912)216:4/5<320::aid-dvdy2>3.0.co;2-h · Cited by 64
González, I., Andreu, E. J., Panizo, A., Inogés, S., Fontalba, A., Fernández-Luna, J. L., Gaboli, M., Sierrasesúmaga, L., Martín-Algarra, S., Pardo, J., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0778-03 · Cited by 80
Pinto, A., Dickman, P. S., & Parham, D. M. (2010) · Sarcoma · doi:10.1155/2011/856190 · Cited by 80
“Specific balanced chromosomal translocations cytogenetically characterize ESFT [45] and create aberrant chimeric fusion oncogenes with different transactivation activities [62].”
BackgroundHaley, B., Paunesku, T., Protić, M., & Woloschak, G. E. (2009) · International Journal of Radiation Biology · doi:10.1080/09553000903009548 · Cited by 80
“…and hnRNP K itself are prospective targets for anticancer therapies. hnRNP P2 Protein hnRNP P2 more commonly known as translocation/fusion protein (TLS/FUS) (Calvio et al. 1995) contains an RNA binding motif flanked by RGG repeats (Delattre et al. 1992, Crosat et al. 1993, Rabbitts et al. 1993).”
BackgroundSancéau, J., Poupon, M., Delattre, O., Sastre‐Garau, X., & Wietzerbin, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205881 · Cited by 86
“…22) (q24:q12) (Aurias et al., 1983; Horowitz et al., 1997) which results in the production of the EWS-Fli-1 fusion protein, a chimeric transcription factor shown to display oncogenic properties (Delattre et al., 1992; Bailly et al., 1993; May et al., 1993; Ouchida et al., 1995; Kovar et al., 1996).”
BackgroundSelf-citationStewart, E., Federico, S., Karlstrom, A., Shelat, A., Sablauer, A., Pappo, A., & Dyer, M. A. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2015.03.001 · Cited by 79
EWS/FLI-1 fusion transcripts in three peripheral primitive neuroectodermal tumors of the kidney
Quezado, M., Benjamin, D. R., & Tsokos, M. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90147-7 · Cited by 79
Weterman, M. A. J., van Groningen, J. J. M., Jansen, A., & van Kessel, A. G. (2000) · Oncogene · doi:10.1038/sj.onc.1203255 · Cited by 79
“For example, in t(11;22)-positive Ewing sarcomas the transactivation domain of EWS is fused to the DNA-binding domain of FLI1, a member of the Ets family of transcription factors (Delattre et al., 1992).”
BackgroundLoss of 14q and 22q in Gastrointestinal Stromal Tumors (Pacemaker Cell Tumors)
Breiner, J. A., Meis‐Kindblom, J. M., Kindblom, L., McComb, E. N., Liu, J., Nelson, M., & Bridge, J. A. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00212-0 · Cited by 79
“, Downers Grove, IL, USA) as previously described [15–18].”
MethodDjavaheri‐Mergny, M., Wietzerbin, J., & Besançon, F. (2003) · Oncogene · doi:10.1038/sj.onc.1206356 · Cited by 79
“Over 90% of Ewing tumors have recurrent reciprocal translocations that join the EWS gene on chromosome 22 to an ETS family gene, either FLI-1 on chromosome 11 or ERG on chromosome 21 (Delattre et al., 1992; Sorensen et al., 1994).”
BackgroundThe impact of Fli1 deficiency on the pathogenesis of systemic sclerosis
Asano, Y., Bujor, A. M., & Trojanowska, M. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.06.008 · Cited by 85
“Ewing sarcomas, a pediatric tumor with neuroectodermal origin [12,13].”
Background
Metadata
- Authors
- Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., Aurias, A., & Thomas, G.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Nature
- Published
- 1992-09
- Volume
- 359
- Issue
- 6391
- Pages
- 162-165
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2069351898
- Cited by
- 1,907
- References
- 30
- Citations by year
- 2026: 57 · 2025: 72 · 2024: 69 · 2023: 64 · 2022: 78 · 2021: 83 · 2020: 80 · 2019: 69 · 2018: 54 · 2017: 57 · 2016: 71 · 2015: 62 · 2014: 61 · 2013: 63 · 2012: 45
- FWCI
- 60.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- Ewing sarcoma, primitive neuroectodermal tumor, 22)(q24, EWSR1, gene fusion, chromosomal translocation, RNA-binding domain
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Chromosomes, Human, Pair 11, Chromosomes, Human, Pair 22, Cloning, Molecular, Gene Frequency, Humans, Molecular Sequence Data, Nucleic Acid Hybridization, Sarcoma, Ewing, Sequence Homology, Nucleic Acid, Transcription, Genetic, Translocation, Genetic, Restriction Mapping, DNA Probes, Polymerase Chain Reaction, Open Reading Frames, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.